Tagged with R&D

Colombia Gustavo Morales, Executive Director of the Association of Pharmaceutical Research and Development Laboratories (AFIDRO) and proud advocate of intellectual property has successfully changed Colombian public opinion on the pharmaceutical industry. In this interview, Gustavo explains how recent regulations will increase the demand of pharmaceutical products as well as the incentives…

Taiwan Gou Jen Wang, the co-founder of Vida BioTechnology, and Bing Chen Gu, General Manager elaborate on how Vida BioTechnology provides added value to its customers by focusing on simplified use, innovation, lower cost and quality in next generation biosensing. Vida BioTechnology was founded in 2014. Can you introduce your company to…

Taiwan Daniel Huang, CEO of Genomics Bioscience, Taiwan’s largest commercial genome sequencing company, and Chairman of Pharmigene, a global leader in the development and manufacturing of genetic tests, documents how he plans to leverage the combined capacity and expertise of these two companies to form strategic alliances with leading pharmaceutical companies…

Taiwan Joshua Chang, CEO of RDD Lab, describes the scope of the company’s operations, the expansion of the firm’s capacities, and emerging trends in the CRO industry. Please begin by introducing yourself and the main operations and services of your CRO. “The local CRO industry has many advantages; the results of…

Taiwan Frank Douglas, CEO of the TheVax, discusses what he finds so inspiring about innovation in resource-constrained environments, and this Taiwanese biotech’s revolutionary SIT specific immunotherapy platform. The company was founded in 2012 with the mission to focus on the use of immunotherapy to address virus-induced tumors and infections in patients.…

Ukraine Dr. Volodymyr Redko, executive director of Ukraine’s Association of Pharmaceutical Research and Development (APRaD), which gathers together 15 international R&D-driven companies, provides insights into the perspective of international innovators vis-à-vis the numerous regulatory and structural reforms that are set to transform the country’s health system, while highlighting the importance that…

Taiwan Ming-Kuei Jang, founder and CEO of Aprinoia, a very promising Taiwan-based company focused on the development of groundbreaking imaging tracers and therapeutics targeting tau-related neurodegenerative diseases, provides insights into the company’s rapid development over the past two years, its R&D strategy, and its eagerness to partner with both academia and…

Taiwan James Yang, Director of the Department of Oncology at National Taiwan University Hospital and Director of the Graduate Institute of Oncology at National Taiwan University, discusses the important role of oncology research in developing the Taiwanese pharmaceutical market as well as the new National Taiwanese University Cancer Center (which will…

Taiwan Johnsee Lee, founder, CEO, and president of Personal Genomics and its sister company Quark Biosciences, provides insights into the company’s proprietary Optoelectronic Sequencing (OES) technology, which can perform whole genome sequencing thousand times faster than existing technologies and increase read length twentyfold in comparison to sequencing products currently on the…

Mexico Marco Cid, Director General of Investigacion Biomedica, shares how he successfully launched an innovative clinical research center (CRC) despite a challenging regulatory environment. He speaks about the inspiration behind his business model, the necessity of building a strong rapport with authoritative entities in the market, as well as fostering a…

Taiwan C.Y. Cheng, chairman and president of Formosa Laboratories, shares exciting news about the establishment of a new drug development company, Formosa Pharmaceuticals. He explains how the know-how gained from running a successful international API production business will help Formosa avoid the typical mistakes that young R&D companies face. Mr. Cheng,…

Taiwan Chih-Yi Weng, chairlady and CEO of Charsire Biotechnology, one of Taiwan’s leading biotech companies focused on the development of botanical new drugs as well as topical and personal care products, provides insights into the company’s unique business model and its promising and maturing R&D pipeline, while Charsire was ranked in…